Industry

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Lysoway Therapeutics, Inc., a biopharmaceutical company developing small molecule modulators of lysosomal ion channels, today announced that it has received a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). Support comes from MJFF’s Parkinson’s Disease Therapeutics Pipeline Program, which focuses on candidates with strong potential to slow or halt … [Read more…]

Santa Swaps Snow for Sunshine at LuskinOIC’s DTLA Campus LOS ANGELES–(BUSINESS WIRE)–#BackToSchool–The spirit of giving came early this year as Luskin Orthopaedic Institute for Children (LuskinOIC) hosted its first-ever Christmas in July celebration. The festive event brought patients, families, staff, and the broader community together for a joyful day of toys, music, crafts, food, and … [Read more…]

Second Quarter Total Revenue of $60.1 Million; Record Product Revenue of $52.4 Million, Up 16% Year-Over-Year Raising Full-Year 2025 Product Revenue Guidance Range to $200 Million – $203 Million Conference Call Today at 4:30 pm ET CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq:CERS) announced financial results for the second quarter ended June 30, 2025, and provided a … [Read more…]

Revolutionary specialized viewers deliver sub-second load times and AI-powered automation to accelerate breast imaging and nuclear medicine workflows SAN FRANCISCO–(BUSINESS WIRE)–New Lantern, the first AI-native complete radiology solution, today announced the launch of two specialized viewer modes: the Mammography Viewer Mode and PET/CT Viewer Mode. These solutions address bottlenecks in breast imaging and breast and … [Read more…]

CHICAGO–(BUSINESS WIRE)–#SCHCapitalHoldings–SCH Capital Holdings, Inc., the nation’s leading human capital information management holding company for health care and not-for-profit/tax-exempt organizations, has acquired Boston-based Statera. Formed in 2020, Statera is a group of human-focused compensation experts and health care technologists who provide timely and actionable compensation and care insights to hospitals, medical groups, and clinicians. Statera’s … [Read more…]

CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quarter ended June 30, 2025. Second Quarter Results and Highlights All comparisons are to the quarter ended June 30, 2024 unless … [Read more…]

AMSTERDAM, ZUG, Switzerland & GDAŃSK, Poland–(BUSINESS WIRE)–Polpharma Biologics S.A. (“Polpharma Biologics”) announces a global (except for Middle East & North Africa) licensing agreement with Fresenius Kabi for the commercialization of PB016, a proposed biosimilar to vedolizumab, an integrin receptor antagonist, (reference product: Entyvio®*), a biologic therapy indicated for moderate to severe ulcerative colitis and Crohn’s … [Read more…]

STAAR Surgical is a leader in refractive surgery using Implantable Collamer Lenses, offering solutions for moderate to high myopes Acquisition of STAAR is complementary to Alcon’s laser vision correction business and is expected to be accretive in year two Alcon to purchase all outstanding shares of STAAR for $28 per share in cash, valuing STAAR … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–Taiwan has taken a bold step in driving regional wellness innovation with the launch of the ‘2025 Go Healthy with Taiwan’ campaign in USA. Spearheaded by the Taiwan International Trade Administration (TITA) under the Ministry of Economic Affairs, and executed by the Taiwan External Trade Development Council (TAITRA), this campaign encourages US public … [Read more…]

ATLANTA–(BUSINESS WIRE)–Regional Health Properties, Inc. (“Regional”) (OTCQB: RHEP) (OTCQB: RHEPA) and SunLink Health Systems, Inc. (“SunLink”) (NYSE American: SSY) jointly announced today that, at special meetings of their respective shareholders each held on August 4, 2025, Regional shareholders and SunLink shareholders approved the merger of SunLink with and into Regional, with Regional as the surviving … [Read more…]